Can serum magnesium stay low despite supplementation?

Serum magnesium monitoring often fails to reflect true total body status, presenting a clinical challenge during oral repletion therapy.

Bioavailability and kinetic barriers

• Formulation discrepancies: Inorganic magnesium oxide exhibits extremely low bioavailability (~4%), whereas organic formulations like magnesium citrate (~28–33%) and magnesium glycinate (~50–80%) are absorbed far more efficiently.
• Dose-dependent transport: Absorption relies on concentration-dependent gastrointestinal kinetics, shifting from active transcellular transport at lower doses to passive paracellular transport at higher concentrations.

Intracellular partitioning and tissue demand

• The intracellular sink: Because over 99% of total body magnesium is stored intracellularly, depleted tissues act as a massive systemic sink during states of chronic deficiency.
• Channel-mediated buffering: Under high cellular repletion demand, newly absorbed magnesium is rapidly partitioned into intracellular pools via TRPM6 and TRPM7 channel activation, buffering and suppressing transient elevations in serum levels.

Exertional depletion and renal clearance

• Sweat and urinary losses: Intense or prolonged physical activity induces significant magnesium losses via sweat at a rate of approximately 10–30 mg per hour and elevates post-exercise urinary excretion by up to 30%.
• Plasma reduction: These combined excretory pathways can acutely lower systemic plasma magnesium levels by approximately 10% following heavy exertion, continuously offsetting oral replacement efforts.

Bottom line

• Serum magnesium levels can remain below optimal during supplementation when poor formulation bioavailability, rapid TRPM6/TRPM7-mediated intracellular diversion, and ongoing exercise-induced sweat and urinary losses collectively outpace daily oral intake.